Group One Trading
PCVX icon

Group One Trading’s Vaxcyte PCVX Stock Holding History

Group One Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$482K Buy
8,300
+8,200
+8,200% +$445K ﹤0.01% 3380
2025
Q4 		$4.61K Sell
100
-800
-89% -$35.8K ﹤0.01% 7217
2025
Q3 		$32.4K Sell
900
-3,000
-77% -$99.4K ﹤0.01% 6305
2025
Q2 		$127K Buy
3,900
+3,800
+3,800% +$125K ﹤0.01% 4755
2025
Q1 		$3.78K Sell
100
-6,900
-99% -$552K ﹤0.01% 6761
2024
Q4 		$573K Sell
7,000
-1,200
-15% -$119K ﹤0.01% 3057
2024
Q3 		$937K Sell
8,200
-2,400
-23% -$216K ﹤0.01% 2354
2024
Q2 		$800K Hold
10,600
– – ﹤0.01% 2174
2024
Q1 		$724K Buy
10,600
+10,500
+10,500% +$727K ﹤0.01% 2389
2023
Q4 		$6.28K Sell
100
-900
-90% -$46.7K ﹤0.01% 6425
2023
Q3 		$51K Sell
1,000
-7,400
-88% -$365K ﹤0.01% 5081
2023
Q2 		$419K Buy
8,400
+5,700
+211% +$270K ﹤0.01% 3193
2023
Q1 		$101K Hold
2,700
– – ﹤0.01% 4297
2022
Q4 		$129K Buy
+2,700
New +$106K ﹤0.01% 4210

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's PCVX Position: Q1 2026 in Review

Group One Trading sold out of Vaxcyte (PCVX) in Q1 2026, closing a stake of 831 shares — an estimated $45.1K sold.

Group One Trading first reported a position in PCVX in Q2 2024 and held it in 3 quarters. The position peaked at $350K in Q4 2024. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Group One Trading reported no remaining Vaxcyte position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 831 Vaxcyte shares in Q1 2026, an estimated $45.1K.
  • Group One Trading first reported a position in Vaxcyte in Q2 2024 and held it in 3 quarters.
  • Group One Trading's Vaxcyte position peaked at $350K in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.